Stocks · News reference

8-K filing — Ensysce Biosciences, Inc. (ENSC)

Aug 25, 2026, 9:12 PMSEC EDGAR

Filed: 2026-08-25 AccNo: 0001493152-26-040080 Size: 204 KB Item 8.01: Other Events

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 13, 2026, 8:45 PMBenzinga Newsdesk
Ensysce Biosciences Q2 EPS $(0.20) Beats $(0.50) Estimate, Sales $1.164M Beat $1.000M Estimate
Ensysce Biosciences (NASDAQ:ENSC) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.50) by 60 percent. This is a 74.68 percent increase over losses of $(0.79) per share from
Read original at benzinga
ENSC
BenzingaAug 6, 2026, 1:43 PMAvi Kapoor
Nasdaq Down 50 Points; US Foods Posts Upbeat Earnings
US stocks trade mixed, Nasdaq falls 50 points. Energy shares up 1.3%, tech stocks down 0.5%. US Foods beats earnings, Clearone Inc surges 203%.
Read original at benzinga
BIVI CLRO ENSC TDUP USFD
BenzingaAug 6, 2026, 1:27 PMBenzinga Newsdesk
Ensyce Biosciences shares are trading higher after the company announced the acquisition of Cy Biopharma and up to $77 million in private financing.
Read original at benzinga
ENSC